| Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference THJ Goodship, HT Cook, F Fakhouri, FC Fervenza, V Frémeaux-Bacchi, ... Kidney international 91 (3), 539-551, 2017 | 652 | 2017 |
| Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome T Manuelian, J Hellwage, S Meri, J Caprioli, M Noris, S Heinen, M Jozsi, ... The Journal of clinical investigation 111 (8), 1181-1190, 2003 | 406 | 2003 |
| Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency M Józsi, C Licht, S Strobel, SLH Zipfel, H Richter, S Heinen, PF Zipfel, ... Blood, The Journal of the American Society of Hematology 111 (3), 1512-1514, 2008 | 390 | 2008 |
| Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome PF Zipfel, M Edey, S Heinen, M Józsi, H Richter, J Misselwitz, B Hoppe, ... PLoS genetics 3 (3), e41, 2007 | 384 | 2007 |
| Factor H family proteins and human diseases M Józsi, PF Zipfel Trends in immunology 29 (8), 380-387, 2008 | 334 | 2008 |
| C3 glomerulopathy—understanding a rare complement-driven renal disease RJH Smith, GB Appel, AM Blom, HT Cook, VD D’Agati, F Fakhouri, ... Nature reviews nephrology 15 (3), 129-143, 2019 | 300 | 2019 |
| Complement and diseases: defective alternative pathway control results in kidney and eye diseases PF Zipfel, S Heinen, M Józsi, C Skerka Molecular immunology 43 (1-2), 97-106, 2006 | 269 | 2006 |
| Anti–factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome M Józsi, S Strobel, HM Dahse, W Liu, PF Hoyer, M Oppermann, C Skerka, ... Blood, The Journal of the American Society of Hematology 110 (5), 1516-1518, 2007 | 268 | 2007 |
| Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit … MA Abrera-Abeleda, C Nishimura, JLH Smith, S Sethi, JL McRae, ... Journal of medical genetics 43 (7), 582-589, 2006 | 252 | 2006 |
| Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II) C Licht, S Heinen, M Jozsi, I Löschmann, RE Saunders, SJ Perkins, ... Kidney international 70 (1), 42-50, 2006 | 247 | 2006 |
| The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein M Oppermann, T Manuelian, M Józsi, E Brandt, TS Jokiranta, S Heinen, ... Clinical & Experimental Immunology 144 (2), 342-352, 2006 | 186 | 2006 |
| Leptospiral immunoglobulin-like proteins interact with human complement regulators factor H, FHL-1, FHR-1, and C4BP MM Castiblanco-Valencia, TR Fraga, LB Silva, D Monaris, PAE Abreu, ... Journal of Infectious Diseases 205 (6), 995-1004, 2012 | 164 | 2012 |
| Factor H-related proteins determine complement-activating surfaces M Józsi, A Tortajada, B Uzonyi, EG de Jorge, SR de Córdoba Trends in immunology 36 (6), 374-384, 2015 | 162 | 2015 |
| Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions M Józsi, S Heinen, A Hartmann, CW Ostrowicz, S Hälbich, H Richter, ... Journal of the American Society of Nephrology 17 (1), 170-177, 2006 | 159 | 2006 |
| Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site TS Jokiranta, ZZ Cheng, H Seeberger, M Jòzsi, S Heinen, M Noris, ... The American journal of pathology 167 (4), 1173-1181, 2005 | 152 | 2005 |
| Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H M Mihlan, S Stippa, M Józsi, PF Zipfel Cell Death & Differentiation 16 (12), 1630-1640, 2009 | 151 | 2009 |
| Factor h: a complement regulator in health and disease, and a mediator of cellular interactions A Kopp, M Hebecker, E Svobodová, M Józsi Biomolecules 2 (1), 46-75, 2012 | 141 | 2012 |
| Anti-factor B autoantibody in dense deposit disease S Strobel, M Zimmering, K Papp, J Prechl, M Józsi Molecular immunology 47 (7-8), 1476-1483, 2010 | 136 | 2010 |
| The C-terminus of complement factor H is essential for host cell protection M Józsi, M Oppermann, JD Lambris, PF Zipfel Molecular immunology 44 (10), 2697-2706, 2007 | 134 | 2007 |
| Factor H and factor H-related protein 1 bind to human neutrophils via complement receptor 3, mediate attachment to Candida albicans, and enhance neutrophil antimicrobial activity J Losse, PF Zipfel, M Józsi The journal of immunology 184 (2), 912-921, 2010 | 129 | 2010 |
